Déclaration d'accessibilité Sauter la navigation
  • Ressources
  • Journalistes
  • Relations investisseurs
  • Webdiffusion
  • English
  • mon CNW 
    • Ouvrir une session
    • Créez un compte
  • Ouvrir une session
  • Inscription
  • Envoyer
Cision Canada
  • Nouvelles
  • Produits
  • Nous joinder
Recherche
When typing in this field, a list of search results will appear and be automatically updated as you type.

Rechercher votre contenu...

Aucun résultat trouvé. Modifiez les termes de votre recherche et réessayez.

News Releases

view all
    Recherche avancée
    • Communiqués
        • Parcourir les communiqués

        • Tous les communiqués de presse
        • Tous les communiqués de sociétés publiques
        • Parcourir tous les communiqués

        • Galerie multimédia

        • Tous les communiqués avec multimédia
        • Tous les communiqués avec photos
        • Tous les communiqués avec vidéos
        • Voir toute la Galerie multimédia

        • Sujets d'actualité

        • Voir tous les sujets d'actualité
    • Affaires
        • Affaires Générales

        • Activités d'externalisation
        • Annonces relatives au personnel
        • Communiqués salon professionnel
        • Enquêtes, sondages et recherches
        • Expansion d'entreprise
        • Immobilier commercial
        • Immobilier résidentiel
        • Investissement socialement responsable
        • Licenciement
        • Nécrologie
        • Nouveaux produits et services
        • Récompenses
        • Ressources humaines et gestion des effectifs
        • Résultats financiers
        • Services aux petites entreprises
        • Transactions immobilières
        • Survol, Affaires Générales

        • Voir tout Affaires Générales

        • Divertissement et médias

        • Art
        • Divertissement
        • Film
        • Livres
        • Magazines
        • Musique
        • Publicité
        • Radio & Baladodiffusion
        • Services de publication et d'information
        • Télévision
        • Survol, Divertissement et médias

        • Voir tout Divertissement et médias

        • Secteur de l’automobile et du transport

        • Aérospatiale, défense
        • Automobile
        • Chaîne logistique / Logistique
        • Compagnies aériennes & Aviation
        • Fret aérien
        • Maritime & Construction navale
        • Tourisme et Voyages
        • Transport, camionnage et de chemin de fer
        • Transports routiers
        • Voies ferrées et transport intermodal
        • Survol, Secteur de l’automobile et du transport

        • Voir tout Secteur de l’automobile et du transport

        • Services financiers et investissements

        • Accords financiers
        • Acquisitions, fusions et rachats
        • Activisme actionnarial
        • Annonces de conférence de presse
        • Assurance
        • Capital de risque
        • Coentreprises
        • Contrats
        • Cryptomonnaie
        • Dividendes
        • Émission d'actions
        • Faillite
        • Fonds communs
        • Fractionnement d'actions
        • Immobilier
        • Nouvelles et dossiers
        • Obligations et actions
        • Opinions d'investissement
        • Placement privé
        • Prévisions de résultats & projections
        • Rapports des ventes
        • Restructuration & recapitalisation
        • Résultats financiers
        • Services bancaires & financiers
        • Survol, Services financiers et investissements

        • Voir tout Services financiers et investissements

        • Technologies des affaires

        • Analyse de données
        • Automatisation de la conception électronique
        • Chaîne de blocs
        • Commerce électronique
        • Composants électroniques
        • Informatique et électronique
        • Logiciel informatique
        • Matériel informatique
        • Nanotechnologie
        • Périphériques
        • Réseaux
        • Sécurité haute technologie
        • Semi-conducteurs
        • Technologie de radiodiffusion
        • Technologie financière
        • Technologie Internet
        • Survol, Technologies des affaires

        • Voir tout Technologies des affaires

    • Sciences et technologie
        • Énergie et ressources naturelles

        • Chimie
        • Commodités
        • Découvertes en matière de pétrole et de gaz
        • Énergies alternatives
        • Fabrication générale
        • Gaz
        • Mines
        • Mines & Métaux
        • Pétrole & Énergie
        • Services d'eau
        • Services d'électricité
        • Survol, Énergie et ressources naturelles

        • Voir tout Énergie et ressources naturelles

        • Environnement

        • Catastrophes naturelles
        • Conservation & Recyclage
        • Politique environnementale
        • Problèmes environnementaux
        • Produits et services environnementaux
        • Technologie verte
        • Survol, Environnement

        • Voir tout Environnement

        • Industries lourdes et manufacturières

        • Aéronautique & Défense
        • Agriculture
        • Chimie
        • Construction & Bâtiment
        • CVC (Chauffage, ventilation et climatisation)
        • Fabrication générale
        • Machinerie
        • Machines-outils, travail des métaux et métallurgie
        • Métaux précieux
        • Mine
        • Mines & Métaux
        • Papier, produits forestiers et conteneurs
        • Tabac
        • Textiles
        • Survol, Industries lourdes et manufacturières

        • Voir tout Industries lourdes et manufacturières

        • Technologie de consommation

        • Analyse de données
        • Chaîne de blocs
        • Chaîne logistique / Logistique
        • Commerce électronique
        • Communications sans fil
        • Cryptomonnaie
        • Divertissement mobile
        • Électronique de consommation
        • Infonuagique / Internet des objets
        • Informatique et électronique
        • Intelligence artificielle
        • Jeux électroniques
        • Logiciel informatique
        • Matériel informatique
        • Médias sociaux
        • Multimédia & Internet
        • Périphériques
        • STIM (Science, technologie, ingénierie, mathématiques)
        • Technologie financière
        • Survol, Technologie de consommation

        • Voir tout Technologie de consommation

        • Télécommunications

        • Carrières et services
        • Communications sans fil
        • Divertissement mobile
        • Équipement de télécommunication
        • Industrie de la télécommunication
        • Périphériques
        • Réseaux
        • VoIP (voix sur IP)
        • Survol, Télécommunications

        • Voir tout Télécommunications

    • Santé et style de vie
        • Divertissement et médias

        • Art
        • Divertissement
        • Film
        • Livres
        • Magazines
        • Musique
        • Publicité
        • Radio & Baladodiffusion
        • Services de publication et d'information
        • Télévision
        • Survol, Divertissement et médias

        • Voir tout Divertissement et médias

        • Produits de consommation et vente au détail

        • Aliments biologiques
        • Aliments et boissons
        • Animaux et animaux domestiques
        • Bières, vins et spiritueux
        • Bijoux
        • Boissons
        • Boissons non-alcoolisées
        • Cannabis
        • Commerce
        • Jouets
        • Ménages, Consommateurs, Cosmétiques
        • Meubles et ameublement
        • Mode
        • Produits cosmétiques et soins personnels
        • Produits d'entretien domestique
        • Produits de bureau
        • Rappels de produit
        • Rénovation domiciliaire
        • Restaurants
        • Services nuptiaux
        • Supermarchés
        • Survol, Produits de consommation et vente au détail

        • Voir tout Produits de consommation et vente au détail

        • Santé

        • Approbation médicale internationale
        • Assurance santé
        • Biométrique
        • Biotechnologie
        • Conditionnement physique / Mieux-être
        • Contrôle des infections
        • Dentisterie
        • Équipement médical
        • Essais cliniques & de Découvertes Médicales
        • Homologation de la FDA
        • Médecines complémentaires
        • Pharmaceuticals médicaux
        • Pharmaceutiques
        • Santé mentale
        • Soins de santé & hôpitaux
        • Survol, Santé

        • Voir tout Santé

        • Sports

        • Équipements et accessoires de sport
        • Événements sportifs
        • Plein air, camping, randonnée pédestre
        • Sports en général
        • Survol, Sports

        • Voir tout Sports

        • Tourisme et Voyages

        • Hôtels et stations
        • Hôtels et stations
        • Industrie du voyage
        • Loisirs et tourisme
        • Parcs d'attraction et attractions touristiques
        • Plein air, camping, randonnée pédestre
        • Trafic aérien de passagers
        • Survol, Tourisme et Voyages

        • Voir tout Tourisme et Voyages

    • Politique et intérêt public
        • Politique et intérêt public

        • Actualités, tendances, analyses économiques
        • Actualités syndicales
        • Bien-être de l'animal
        • But non lucratif
        • Catastrophes naturelles
        • Direction & Agence fédérale exécutif
        • Éducation
        • Environnement
        • Gouvernement européen
        • Homologation de la FDA
        • Législation fédérale et nationale
        • Opinion du groupe de défense des droits
        • Politique commerciale
        • Politique étrangère
        • Politique fédérale
        • Politique intérieure
        • Politique municipale
        • Politique provinciale
        • Questions juridiques
        • Responsabilité sociale de l'entreprise
        • Sécurité intérieure
        • Sécurité publique
        • Survol, Politique et intérêt public

        • Voir tout Politique et intérêt public

    • Société
        • Société

        • Actualités liées aux Afro-américains
        • Actualités liées aux Asiatiques
        • Actualités liées aux enfants
        • Actualités liées aux femmes
        • Actualités liées aux personnes handicapées
        • Actualités orientées vers les hispaniques
        • Anciens combattants
        • Autochtones, Premières Nations et Amérindiens
        • Diversité, équité & inclusion
        • Intérêt des hommes
        • Lesbienne, Homosexuel, Bisexuel
        • Personnes du troisième âge
        • Religion
        • Survol, Société

        • Voir tout Société

    • Recherche avancée
    • Découvrir la plateforme
    • Planifier des campagnes
    • Créer avec l'IA
    • Diffuser des communiqués
    • Mesurer vos résultats
    • Amplifier le contenu
    • Devenir un client
    • Demandez une démo
    • Bureaux d'édition
    • Partenariats
    • Renseignements généraux
    • Médias
    • Bureaux Mondiaux
    • Hamburger menu
    • Cision Canada
    • Envoyer
    • EN
      • Téléphone

      • 877-269-7890 de 8h00 à 22h00

      • Contactez Cision
      • Contactez Cision

        877-269-7890
        de 8h00 à 22h00

    • Rechercher votre contenu...

      Aucun résultat trouvé. Modifiez les termes de votre recherche et réessayez.

      News Releases

      view all
      Close menu
    • Nouvelles
    • Produits
    • Nous joinder
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • 3 Communiqués
      • 5 Affaires
      • 5 Sciences et technologie
      • 5 Santé et style de vie
      • 1 Politique et intérêt public
      • 1 Société
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • Découvrir la plateforme
      • Planifier des campagnes
      • Créer avec l'IA
      • Diffuser des communiqués
      • Mesurer vos résultats
      • Amplifier le contenu
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      • Devenir un client
      • Demandez une démo
      • Bureaux d'édition
      • Partenariats
      • Renseignements généraux
      • Médias
      • Bureaux Mondiaux
      • Envoyez un communiqué
      • Inscription
      • Ressources
      • Blogue
      • Journalistes
      • Webdiffusion
      • RGPD
      Close submenu (Communiqués) Communiqués
      • Parcourir les communiqués
      • Galerie multimédia
      • Sujets d'actualité
      Close submenu (Affaires) Affaires
      • Affaires Générales
      • Divertissement et médias
      • Secteur de l’automobile et du transport
      • Services financiers et investissements
      • Technologies des affaires
      Close submenu (Sciences et technologie) Sciences et technologie
      • Énergie et ressources naturelles
      • Environnement
      • Industries lourdes et manufacturières
      • Technologie de consommation
      • Télécommunications
      Close submenu (Santé et style de vie) Santé et style de vie
      • Divertissement et médias
      • Produits de consommation et vente au détail
      • Santé
      • Sports
      • Tourisme et Voyages
      Close submenu (Politique et intérêt public) Politique et intérêt public
      • Politique et intérêt public
      Close submenu (Société) Société
      • Société

      Dialogue Health Technologies Reports Second Quarter 2022 Results

      Dialogue Logo (CNW Group/Dialogue Health Technologies Inc.)

      Nouvelles fournies par

      Dialogue Health Technologies Inc.

      10 août, 2022, 16:30 ET

      Partager cet article

      Partager cet article


      Strong organic growth, improved gross margin, and solid cost control provide increasing confidence in profitability objectives for 2023

      MONTREAL, Aug. 10, 2022 /CNW/ - Dialogue Health Technologies Inc. (TSX: CARE) ("Dialogue" or the "Company"), Canada's premier health and wellness virtual healthcare platform, announced today its financial and operational results for the three and six months ended June 30, 2022. Financial references are in Canadian dollars unless otherwise indicated.

      "Dialogue continued to execute well and delivered solid revenue growth, winning further market share across all our services," said Cherif Habib, Chief Executive Officer of Dialogue. "With the acquisition of Tictrac, we made significant progress on our journey towards becoming a holistic platform, adding prevention to our existing physical and mental health treatment solutions.  We launched an early access version of our new Wellness service, which has been progressing rapidly in Canada and generating much interest from our customers. We also strengthened our two largest partnerships and are well positioned to keep delivering on our growth objectives."

      Navaid Mansuri, Chief Financial Officer, added: "In the first half of the year, we took important steps to drive efficiencies in our operations, and this has begun to show in our second quarter performance.  We implemented further pricing increases and are pleased with the low customer churn, a testament to our great value proposition. Thanks to our healthy balance sheet, we are sufficiently capitalized to reach our profitability targets in 2023 while continuing to invest in the growth of our business and innovating for our customers, as well as exploring further M&A opportunities."

      Q2 2022 Financial Highlights
      (All capitalized terms not defined herein, shall have the meaning and usefulness ascribed to them in the Management's Discussion and Analysis for the three and six months ended June 30, 2022. Comparison periods in each case are the three and six months ended June 30, 2021, unless otherwise stated.)

      • Annual Recurring and Reoccurring Revenue ("ARR") grew 38.7% year-over-year to $97.1 million, driven largely by new Customer wins and supplemented by a partial quarter of contribution from the acquisition of Tictrac Ltd. ("Tictrac"). New customer wins include a global leader in information management that adopted our Primary Care service, a multinational HR consultancy and a provincial non-profit organization that signed on for our Employee Assistance Program ("EAP"), and a large Canadian financial advisory firm that added our full Integrated Health PlatformTM. We also saw several important program expansions and the addition of new services by existing Customers, including a provincial Crown corporation that added our EAP and Mental Health, and a North American leader in transportation and logistics that added our EAP.
      • Revenue in the second quarter of 2022 increased by 38.3% year-over-year to $23.0 million, due to growth in Members, both Direct and from agreements with strategic distribution partners, an increase in the Attach Rate as existing Customers add more services, and the acquisition of Tictrac.
      • Members grew to nearly 2.4 million, an increase of approximately 950,000, or 65.1%, year-over-year, and more than 350,000, or 17.3%, compared to the first quarter of 2022. Excluding the contribution from Tictrac, Members grew 46.8% year-over-year to 2.1 million.
      • Attach Rate grew to 1.52 from 1.10 in the second quarter last year.
      • Member-Service Units ("MSUs"), which we define as total Members multiplied by the Attach Rate, rose 128.1% year-over-year to more than 3.6 million from approximately 1.6 million in the second quarter last year. Excluding the contribution from Tictrac, MSUs grew 110.9% year-over-year to nearly 3.4 million. This meaningful increase demonstrates the success of Dialogue's land & expand strategy, as both existing and new Customers continue to leverage our platform.
      • 65% of new direct Members signed up for two services or more in the second quarter of 2022. Combined with current Customer expansions, the cumulative number of direct Members with two or more services was 24% at the end of the second quarter of 2022, compared to 18% at the same time last year and 21% at the end of the fourth quarter of 2021.
      • Average Monthly Net Retention Rate ("NRR") was 100.4% for the second quarter of 2022, marking another consecutive quarter of NRR greater than 100%. Churn within our mid-market and enterprise customer segments remained low in the period at approximately 1,500 members.
      • Gross Margin increased to 49.7%, compared to 41.5% in the second quarter of 2021, as we realized efficiencies in our operations, implemented pricing increases to eligible Customers, continued to scale our Mental Health service and EAP, migrated additional Customers from Optima to our Dialogue EAP, and integrated Tictrac's higher margin Wellness service.
      • Adjusted EBITDA1 loss was $4.8 million, compared to a loss of $5.7 million in the same period last year. The smaller loss was due to higher gross profit and strong cost control, partially offset by a deficit at Tictrac.
      • Net loss was $8.4 million, compared to $6.7 million in the same period last year. The larger loss was primarily due to higher share-based payments expense year-over-year, to costs related to the Tictrac acquisition, and to a foreign exchange loss of $1.3 million as the Euro and British pound sterling both depreciated meaningfully during the period in relation to the Canadian dollar.
      • Cash and Cash Equivalents were $61.1 million as of June 30, 2022, compared to $104.3 million as of December 31, 2021. The decrease was the result of cash used in operations during the first six months of the year as well as the initial cash outlay to close the acquisition of Tictrac.

      __________________________________

      1  Adjusted EBITDA is a Non-IFRS financial measure. Refer to the reconciliation contained in the Non-IFRS Financial Measures section, beginning on page 3 of this earnings release.

      Q2 2022 Business Highlights and Subsequent Events

      • On April 13, 2022, we acquired London, UK-based Tictrac Ltd. for up to $56 million (£35 million), subject to certain earn-out conditions. Tictrac is a SaaS-based provider of a global health and wellness platform that enables healthier living for everyone. The transaction was closed successfully on April 30, 2022.
      • On April 21, 2022, we launched Mental Health+, a program that streamlines our existing mental health services and emphasizes seamless integration of varying levels of intervention across the care continuum.
      • On May 16, 2022, Melissa Kennedy was elected to Dialogue's Board of Directors. Mrs. Kennedy is Executive Vice-President, Chief Legal Officer & Public Affairs at Sun Life, where she is responsible for the global legal, compliance, corporate secretarial and public affairs functions. Mrs. Kennedy is also Sun Life's executive sponsor of sustainability.
      • Subsequent to quarter end, on July 4, 2022, Sun Life added Dialogue's Mental Health service to their Lumino Health Virtual Care platform, complementing their existing Primary Care, EAP, and iCBT offering. This additional service is available on an opt-in basis and now permits our largest insurance partner to offer Dialogue's full suite of fully integrated services.
      • For a third consecutive year, we have been certified as a Great Place to WorkTM organization by Great Place to Work® Canada. This employee-validated recognition positions Dialogue well to get noticed as an employer of choice and attract great talent, while branding Dialogue as a company that cares and wins the attention and loyalty of customers.
      • We were recognized by Great Place to Work® in the 2022 Best WorkplacesTM in Canada, 2022 Best WorkplacesTM for Today's Youth, and 2022 Best WorkplacesTM for Giving Back categories.

      Upcoming events

      • Canaccord Genuity 42nd Annual Growth Conference in Boston on August 11, 2022.
      • CIBC 21st Annual Eastern Institutional Conference in Montreal on September 21, 2022.

      Notice of Conference Call

      Dialogue will host a live video webinar on Thursday, August 11, 2022 at 8:00 a.m. ET to discuss its financial results. Cherif Habib, CEO, and Navaid Mansuri, CFO, will co-chair the call. All interested parties can join the event at the following link, which is also available in the Events and Presentations section of the Company's website. The presentation will be accompanied by slides, which will be available on the screen view and will be made available prior to the start of the webinar on  the Company's website. Please connect at least 15 minutes prior to the event to ensure adequate time for any software download of Zoom that may be required to attend the event. Listeners that prefer to dial in by phone may do so by accessing the same web link and the dial in details will be provided by email upon registration.

      Non-International Financial Reporting Standards ("IFRS") Financial Measures

      This press release makes reference to certain non-IFRS measures, such as "EBIT" represents net profit or loss before net financing (income) expenses and income taxes,  "EBITDA" (which stands for net profit or loss before net financing (income) expenses, income taxes, depreciation of property and equipment, amortization of intangible assets, and amortization of right-of-use assets) and "Adjusted EBITDA" (which stands for net profit or loss before net financing (income) expenses, income taxes, depreciation of property and equipment, amortization of intangible assets, amortization of right-of-use assets, transaction costs, acquisition costs, change in fair value of conversion feature, share-based payments expense, change in fair value of contingent consideration, restructuring costs, and foreign exchange gain or loss). These measures are not recognized under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management's perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information as reported under IFRS. Management also believes that other users, such as securities analysts, investors and other interested parties, frequently use non-IFRS measures, particularly in the evaluation of issuers.

      Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts and to determine components of management compensation. Where applicable, we provide a clear quantitative reconciliation from the non-IFRS financial measures to the most directly comparable measure calculated in accordance with IFRS.

      The following table reconciles net loss to Adjusted EBITDA loss for the three and six months ended June 30, 2022 and 2021:

      DIALOGUE HEALTH TECHNOLOGIES INC.
      ADJUSTED EBITDA
      FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022 and 2021

      (in thousands of CAD)


      Three months ended

      June 30,


      Six months ended

      June 30,



      2022


      2021


      2022


      2021



      $


      $


      $


      $










      Net loss


      (8,386)


      (6,669)


      (15,454)


      (237,904)

      Net financing (income) expenses


      (169)


      (126)


      (194)


      62

      Current income tax (expense)


      25


      —


      48


      —

      Deferred income tax recovery


      (166)


      (49)


      (251)


      (155)

      EBIT


      (8,696)


      (6,844)


      (15,851)


      (237,997)

      Depreciation of property and equipment


      256


      157


      404


      266

      Amortization of intangible assets


      504


      374


      906


      704

      Amortization of right-of-use assets


      201


      150


      351


      298

      EBITDA


      (7,735)


      (6,163)


      (14,190)


      (236,729)

      Share-based payments expense


      954


      290


      1,522


      387

      Acquisition costs


      541


      136


      634


      181

      Change in fair value of conversion feature


      —


      —


      —


      225,417

      Change in fair value of contingent consideration


      43


      —


      134


      —

      Restructuring costs


      15


      —


      15


      —

      Foreign exchange loss (gain)


      1,334


      87


      1,334


      87

      Adjusted EBITDA


      (4,848)


      (5,650)


      (10,551)


      (10,657)

      About Dialogue

      Incorporated in 2016, Dialogue is Canada's premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. Through our team of health professionals, we serve employers and organizations who have an interest in the health and well-being of their employees, members and their families. Our Integrated Health Platform™ is a one-stop healthcare hub that centralizes all of our programs in a single, user-friendly application, providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet.

      Forward-Looking Information

      This release includes "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking information may relate to our financial outlook (including revenues and Adjusted EBITDA), and anticipated events or results and may include information regarding our financial position, business strategy, growth strategies, addressable markets, budgets, operations, financial results, taxes, dividend policy, plans and objectives.

      In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward-looking terminology such as "plans" "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management's current beliefs, expectations, estimates and projections regarding future events and operating performance.

      Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Dialogue as of the date of this release, are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ, possibly materially, from those indicated by the forward-looking statements include, but are not limited to, the risk factors identified under "Risk Factors" in the Company's latest annual information form, and in other periodic filings that the Company has made and may make in the future with the securities commissions or similar regulatory authorities in Canada, all of which are available under the Company's SEDAR profile at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect Dialogue. However, such risk factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. Dialogue undertakes no obligation to publicly update any forward-looking statement, except as required by applicable securities laws.

      Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not currently known to us or that we currently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, you should not place undue reliance on forward-looking information. The forward-looking information represents our expectations as of the date of this earnings release (or as the date it is otherwise stated to be made) and is subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable Canadian securities laws. All of the forward-looking information contained in this earnings release is expressly qualified by the foregoing cautionary statements.

      DIALOGUE HEALTH TECHNOLOGIES INC.

      INTERIM CONDENSED CONSOLIDATED STATEMENT OF NET LOSS AND OTHER COMPREHENSIVE INCOME
      FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022 AND 2021

      (in thousands of CAD except share and per share data)

      Three months ended

      June 30,


      Six months ended

      June 30,


      2022


      2021


      2022


      2021


      $


      $


      $


      $









      Revenue

      23,038


      16,660


      43,724


      31,898

      Cost of services

      11,593


      9,751


      23,519


      18,659

      Gross profit

      11,445


      6,909


      20,205


      13,239









      Operating expenses








      General and administrative

      13,672


      8,249


      23,117


      15,832

      Sales and marketing

      3,162


      2,998


      6,389


      5,397

      Product and development

      2,353


      2,216


      5,028


      4,203

      Share-based payments expense

      954


      290


      1,522


      387


      20,141


      13,753


      36,056


      25,819









      Operating loss

      (8,696)


      (6,844)


      (15,851)


      (12,580)









      Other expenses








      Change in fair value of conversion feature

      —


      —


      —


      225,417

      Net financing (income) expenses

      (169)


      (126)


      (194)


      62


      (169)


      (126)


      (194)


      225,479









      Net loss before income taxes

      (8,527)


      (6,718)


      (15,657)


      (238,059)

      Current income tax (expense)

      (25)


      —


      (48)


      —

      Deferred income tax recovery

      166


      49


      251


      (155)

      Net loss

      (8,386)


      (6,669)


      (15,454)


      (237,904)

















      Other comprehensive income















      Items that may be reclassified subsequently to net loss







      Foreign currency translation gain

      254

      318


      613


      629









      Total comprehensive loss

      (8,132)


      (6,351)


      (14,841)


      (237,275)









      Loss per share - basic and diluted

      (0.13)


      (0.10)


      (0.23)


      (5.12)

      DIALOGUE HEALTH TECHNOLOGIES INC.

      INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
      AS AT JUNE 30, 2022 AND DECEMBER 31, 2021

      (in thousands of CAD)

      June 30,


      December 31,




      2022


      2021




      $


      $



      Assets






      Current assets






      Cash and cash equivalents

      61,065


      104,296



      Trade and other receivables

      17,673


      13,659



      Prepaid expenses

      3,801


      1,811




      82,539


      119,766









      Investment

      1,004


      —



      Property and equipment

      1,279


      1,137



      Right-of-use assets

      1,768


      1,568



      Intangible assets

      9,616


      5,819



      Goodwill

      30,203


      6,963



      Deferred income tax asset

      3,227


      —




      129,636


      135,253



      Liabilities






      Current liabilities






      Trade payable and accrued liabilities

      9,915


      9,534



      Unearned revenue

      759


      68



      Current portion of contingent consideration payable

      8,171


      718



      Current portion of long-term debt

      400


      400



      Current portion of lease liabilities

      900


      541




      20,145


      11,261









      Non-current portion of lease liabilities

      731


      911



      Non-current portion of long-term debt

      874


      1,074



      Non-current portion of contingent consideration payable

      560


      1,300



      Deferred income tax liability

      784


      766




      23,094


      15,312



      Commitments and contingencies












      Shareholders' equity






      Share capital

      459,056


      458,962



      Equity reserve

      4,862


      3,514



      Cumulative translation adjustment

      960


      347



      Deficit

      (358,336)


      (342,882)




      106,542


      119,941




      129,636


      135,253









      DIALOGUE HEALTH TECHNOLOGIES INC.

      INTERIM CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
      FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2021

      (in thousands of CAD)

      Six months ended

      June 30,


      2022


      2021


      $


      $

      Operating activities




      Net loss

      (15,454)


      (237,904)

      Items not affecting cash




      Increase (Decrease) on contingent consideration - Optima

      —


      (358)

      Increase (Decrease) on contingent consideration - eHH

      134


      —

      Deferred income tax recovery

      (251)


      (154)

      Change in conversion feature on preferred shares

      —


      225,417

      Depreciation of property and equipment

      404


      266

      Amortization of right-of-use assets

      351


      298

      Net financing (income) expenses

      (194)


      62

      Amortization of intangible assets

      906


      704

      Share-based payments

      1,522


      387


      (12,582)


      (11,282)

      Net changes in non-cash operating working capital items




      Trade and other receivables

      (4,014)


      (1,728)

      Prepaid expenses

      (1,990)


      (2,378)

      Trade and other payables

      381


      2,125

      Unearned revenue

      691


      237

      Interest paid

      (84)


      (62)

      Interest income

      222


      250


      (17,376)


      (12,838)





      Investing activities




      Purchase of property and equipment

      (419)


      (360)

      Purchase of intangible assets

      (1)


      (32)

      Sale of asset held for sale

      —


      910

      Acquisition of Botfront

      —


      (292)

      Acquisition of e-hub Health Pty Ltd. net of cash acquired

      —


      (3,138)

      Investment

      (1,004)


      —

      Acquisition of Tictrac Ltd. net of cash acquired

      (24,253)


      —


      (25,677)


      (2,912)

      Financing activities




      Issuance of shares

      —


      100,008

      Share issue costs

      —


      (9,371)

      Performance share units settled in cash

      (172)


      —

      Options exercised

      92


      480

      Repayment of liability related to asset held for sale

      —


      (430)

      Repayment of long-term debt

      (200)


      (200)

      Repayment of lease liabilities

      (511)


      (406)


      (791)


      90,081

      Effect of foreign currency translation

      613


      629

      Net (decrease) increase in cash and cash equivalents

      (43,231)


      74,960

      Cash and cash equivalents, beginning of the period

      104,296


      42,067

      Cash and cash equivalents, end of the period

      61,065


      117,027

      SOURCE Dialogue Health Technologies Inc.

      Investor relations, Jean Marc Ayas, Director, Investor Relations, [email protected]; Media Relations, Jean-Christophe de Le Rue, Director, Public and Government Relations, [email protected] / (613) 806-0671

      Modal title

      Profil de l'entreprise

      Dialogue Health Technologies Inc.

        Autres communiqués de la compagnie

      • Dialogue lance le Profil de Santé pour aider les Canadiens à comprendre leurs risques de santé et à agir

      • Le bien-être des employés canadiens continue de décliner alors que les employeurs peinent à mesurer et à améliorer les résultats

      • Une étude révèle que les soins virtuels de santé mentale financés par l'employeur pourraient faire économiser 22 milliards de dollars par année au Canada

      Communiquer avec PR Newswire

      • 877-269-7890
        De 7 h 30 à 18 h 30 (HE)
      • Devenir un client
      • Demander une démo
      • Bureaux d'édition
      • Partenariats
      • Renseignements généraux
      • Médias
      • Bureaux mondiaux

      Produits

      • Découvrez la plateforme
      • Planifier des campagnes
      • Créer avec l'IA
      • Diffuser des communiqués
      • Mesurer vos résultats
      • Amplifiez le contenu
      • Relations investisseurs

      À propos

      • À propos de Cision
      • Carrières
      • Énoncé d'accessibilité

      Services

      • Toutes les nouvelles
      • Connexion à la plateforme
      • mon CNW
      • Protection des données

      Ne pas vendre ou partager mes informations personnelles:

      • Soumettre à [email protected] 
      • Appelez gratuitement notre département de la protection de la vie privée: 877-297-8921

      Communiquer avec Cision

      Produits

      À propos

      Services
      • Toutes les nouvelles
      • Comms Cloud Nouvelle Génération
      • Cision Communications Cloud®
      • Plateforme
      • mon CNW
      877-269-7890
      de 8h00 à 22h00
      • Modalités d'utilisation
      • Politique sur la sécurité des données
      • Plan du site
      • Paramètres de cookies
      • Énoncé d'accessibilité
      © Groupe CNW Ltée 2026 Tous droits réservés. Une société Cision.